Detalhe da pesquisa
1.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Breast Cancer Res Treat
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767786
2.
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
Int J Clin Oncol
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753042
3.
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
Int J Clin Oncol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722486
4.
TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer.
Proc Natl Acad Sci U S A
; 118(35)2021 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433666
5.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
N Engl J Med
; 382(7): 610-621, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31825192
6.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Breast Cancer Res Treat
; 202(3): 485-496, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676450
7.
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 53(3): 203-211, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484305
8.
Prognosis and effectiveness of chemotherapy for medullary breast carcinoma.
Breast Cancer Res Treat
; 196(3): 635-645, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273358
9.
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
BMC Med
; 20(1): 136, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462552
10.
Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 52(6): 545-553, 2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296894
11.
Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer.
Acta Med Okayama
; 76(2): 105-111, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35503437
12.
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(1): 74-84, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387497
13.
Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
Support Care Cancer
; 29(10): 6119-6125, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33797582
14.
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Support Care Cancer
; 29(1): 437-443, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32388615
15.
Risk factors of impairment of shoulder function after axillary dissection for breast cancer.
Support Care Cancer
; 29(2): 771-778, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468131
16.
Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
Int J Clin Oncol
; 26(7): 1229-1236, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33891194
17.
Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.
Int J Clin Oncol
; 26(1): 1-17, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161452
18.
Influence of and Risk Factors for Axillary Web Syndrome Following Surgery for Breast Cancer.
Acta Med Okayama
; 75(1): 39-44, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649612
19.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Acta Med Okayama
; 75(3): 357-362, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176940
20.
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
N Engl J Med
; 376(22): 2147-2159, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28564564